THE IMPORTANCE OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN DIFFERENTIATION OF MALIGNANT AND BENIGN OVARIAN LESIONS
Abstract
Introduction: Ovarian cancer is the first on the list of mortality among all female genital cancers. However, there is no successful screening program for ovarian cancer detection. MRI has an important role in diagnostics of adnexal tumor with female patients. The use of diffusion weighted MRI (DWI) is getting more significant to help differentation benign and malignant ovarian lesions.
Goals: Value Evaluation of ADC coefficient values in differentiation between benign and mignant ovarian lesions; correlation of ovarian and uterus ADC coefficient values in groups of female patients with or without malignant ovarian lesions.
Materials and methods: The research has been conducted between the years of 2014 and 2017, as a retrospective clinical study in Radiology center of Clinical Centar of Vojvodina in Novi Sad. 45 female patients have been selected and sorted into 3 groups; First group has benign ovarian lesions, the second group malignant ovarian lesions and the third group with no ovarian lesions. ADC coefficient level has been measured on all the patients in three different places on the lesion itself, while patients with no lesions had their normal tissue measured. The ADC coefficient level has also been measured on the normal part of each patient’s uterus.
Results: The analysis and comparison of ADC coefficient between the three groups point out on statistical significant difference of values of ADC coefficient with patients with malignant lesions and ones with benign or no lesions at all.
Conclusion: The ADC coefficient level has been recognized as a very relevant detector of malignant ovarian lesions during MRI examination.
Key words: Magnetic resonance imaging (MRI), ADC coefficient, malignant ovarian lesions
References
Gates MA, Rosner BA, Hecht JL, Tworoger SS. Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype. Am. J. Epidemiol. 2010; 171(1):45-53.
Stojanović S. Kompjuterizovana tomografija abdomena i karlice. Prvo izdanje. Novi Sad: Medicinski fakultet Novi Sad;2016.
Fan X, Zhang H, Meng S, et al. Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors. Int J Clin Exp Med. 2015; 8:19928-37.
Meng XF, Zhu SC, Sun SJ, et al. Diffusion weighted imaging for the differential diagnosis of benign vs. malignant ovarian neoplasms. Oncol Lett 2016; 11:3795–802.
Đurđev S, Kopitović V, Kapamadžija A. Ginekologija. Prvo izdanje. Novi Sad: Medicinski fakultet Novi Sad; 2015.
Addley H, Moyle P, Freeman S. Diffusion-weighted imaging in gynaecological malignancy. Clinical Radiol. 2017; 72(11):981-990.
J. Hunn and G. Rodriguez. Ovarian Cancer: Etiology, Risk Factors, and Epidemiology. Clinical Obstetrics & Gynecology. 2012; 55(1):3–23.
S. Đurđević i V. Kesić. Ginekološka onkologija. Prvo izdanje. Novi Sad: Medicinski fakultet Novi Sad; 2009.
Kovač JD, Terzić M, Mirković M, et al. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors. Acta radiol. 2015; 57:758–66.
Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y. Role of diffusion- weighted imaging in the diagnosis of gynecological diseases. Eur Radiol. 2009; 19(3):745– 760.
Xia Y, Linghong G, Wei D, Fei M. Diagnostic accuracz of DWI in patients with ovarian cancer. Medicine Baltimore. 2017; 96(19):66-59.
Nakayama T, Yoshimitsu K, Irie H, Aibe H, Tajima T, Nishie A. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas. J Magn Reson Imaging. 2005; 22:271–8.
Zhang P, Cui Y, Li W, et al. Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5 T. World J Surg Oncol. 2012; 10:1.
Einarsd´ottir H, Karlsson M, Wejde J, Bauer HC. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol. 2004; 14:959–63.
Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y. Role of diffusion- weighted imaging in the diagnosis of gynecological diseases. Eur Radiol. 2009; 19:745–60.
Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007; 188(6): 1622–1635.
Vilanova JC, Barcelo´ J. Diffusion-weighted whole-body MR screening. Eur J Radiol. 2008; 67:440–7.
Li W, Chu C, Cui Y, Zhang P, Zhu M. Diffusion-weighted MRI:a useful technique to descriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging. 2012; 37(5):897-903.
Reischauer C, Vorburger RS, Wilm BJ, Jaermann T, Boesiger P. Optimizing signal-to-noise ratio of high-resolution parallel single-shot diffusion-weighted echo-planar imaging at ultrahigh field strengths. Magn Reson Med. 2012; 67:679–690.
Fujii S, Kakite S, Nishihara K, Kanasaki Y, Harada T, Kigawa J, et al. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign form malignant ovarian lesions. J Magn Reson Imaging. 2008; 28(5):1149-56.
Lindgren A, Anttila M, Rautiainen S, Arponen O, Kivelä A, Mäkinen P et al. Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI. Eur Radiol. 2017;27(9):4002-4012.
Zhang H, Zhang GF, Wang TP, Zhang H. Value of 3.0 T diffusion-weighted imaging in discriminating thecoma and fibrothecoma from other adnexal solid masses. J Ovarian Res. 2013; 6(1):58.
Kozawa E, Inoue K, Tanaka J, Meguro S, Yasuda M, Fujiwara K et al. Unusual MR findings in ovarian leiomyoma. Magn Reson Med Sci. 2013; 12(1):57-61.